Hangzhou, China

Biologics development and aseptic fill finish integrated facility

Thermo Fisher’s Hangzhou site combines industry-leading biologics development with aseptic formulation and manufacturing services, all under one roof. The facility leverages decades of experience in contract development and manufacturing to deliver quality mammalian biopharmaceuticals, as well as drug product forms for preclinical, early development, late phase, and commercialization.

The site is also home to our Quick to Clinic for Biologics™ solution, which enables our customers to accelerate their molecule development timelines from preclinical to IND/IMPD.

For customers who want a one-stop shop solution in China, our Hangzhou site adds drug development and manufacturing to our list of existing solutions for clinical trial supply and logistics, as well as CRO capabilities. Look no further for a truly integrated, end-to-end CRO/CDMO offering that serves China and the world beyond.

Kanhong Road, Hangzhou
Biotech Valley, Xiaoshan District
Hangzhou City, Zhejiang, China

Bioproduction technologies at the Hangzhou, China site

Hangzhou, China site offerings:

The 80,000-square-meter, state-of-the-art facility features sustainable construction design, flexible laboratory and production suites, integrated aseptic fill finish technology, and digital connectivity and data visibility to enable operational efficiencies. Thermo Fisher’s advanced bioproduction technologies — including single-use equipment with up to 2,000L scale — are utilized within the suites, with future investments planned for bioreactor capacity up to 5,000L scale.

Biologics development and aseptic fill finish capabilities:

  • Integrated drug substance and drug product manufacturing
  • In-house analytical expertise, QC, and QA
  • Expertise in fed batch and perfusion process
  • In-house and partnered cell line development
  • Single-use technologies and flexible facility design
  • Upstream and downstream process development expertise
  • Prefilled syringes and prefilled cartridges
  • Sterile liquid vials
  • Sterile lyophilized vials
  • Clinical to commercial scale filling
In-house QC expertise at Hangzhou, China site

Drug product delivery forms at Hangzhou facility:

Size / details Early Development (into part of phase ll) Late development Commercial supply
Formulation Development
Analytical Development
Phase l
Phase l
Phase ll
Commercial scale up
Tech transfer
Liquid vials
Lyophilized vials
Prefilled syringes
Prefilled cartridges

Available now
Future capabilities


To learn more about the Hangzhou site’s capabilities and equipment, contact us or download the fact sheet.

Helpful Resources